Kane JM - Search Results

1

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

Kane JM, Robinson DG, Schooler NR, Mueser KT, Penn DL, Rosenheck RA, Addington J, Brunette MF, Correll CU, Estroff SE, Marcy P, Robinson J, Meyer-Kalos PS, Gottlieb JD, Glynn SM, Lynde DW, Pipes R, Kurian BT, Miller AL, Azrin ST, Goldstein AB, Severe JB, Lin H, Sint KJ, John M, Heinssen RK. Kane JM, et al. Am J Psychiatry. 2016 Apr 1;173(4):362-72. doi: 10.1176/appi.ajp.2015.15050632. Epub 2015 Oct 20. Am J Psychiatry. 2016. PMID: 26481174 Free PMC article. Clinical Trial.

2

The prevalence of tardive dyskinesia.

Woerner MG, Kane JM, Lieberman JA, Alvir J, Bergmann KJ, Borenstein M, Schooler NR, Mukherjee S, Rotrosen J, Rubinstein M, et al. Woerner MG, et al. Among authors: kane jm. J Clin Psychopharmacol. 1991 Feb;11(1):34-42. J Clin Psychopharmacol. 1991. PMID: 1674949

3

The current status of neuroleptic therapy.

Kane JM. Kane JM. J Clin Psychiatry. 1989 Sep;50(9):322-8. J Clin Psychiatry. 1989. PMID: 2570063 Review.

4

Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group.

Hargreaves WA, Kane JM, Ninan PT, Severe JB, Woerner M. Hargreaves WA, et al. Among authors: kane jm. Psychopharmacol Bull. 1989;25(3):340-3. Psychopharmacol Bull. 1989. PMID: 2626512

5

Outcome study of first-episode psychosis. I: Relapse rates after 1 year.

Rabiner CJ, Wegner JT, Kane JM. Rabiner CJ, et al. Among authors: kane jm. Am J Psychiatry. 1986 Sep;143(9):1155-8. doi: 10.1176/ajp.143.9.1155. Am J Psychiatry. 1986. PMID: 2875663

6

Research diagnoses for tardive dyskinesia.

Schooler NR, Kane JM. Schooler NR, et al. Among authors: kane jm. Arch Gen Psychiatry. 1982 Apr;39(4):486-7. doi: 10.1001/archpsyc.1982.04290040080014. Arch Gen Psychiatry. 1982. PMID: 6121550 No abstract available.

7

Tardive dyskinesia workgroup report.

Kane JM, Schooler NR. Kane JM, et al. Psychopharmacol Bull. 1980 Jul;16(3):35-6. Psychopharmacol Bull. 1980. PMID: 7403396 No abstract available.

8

Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.

Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J, et al. Szymanski S, et al. Among authors: kane j. Am J Psychiatry. 1995 May;152(5):698-703. doi: 10.1176/ajp.152.5.698. Am J Psychiatry. 1995. PMID: 7726309

9

Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients.

Kronig MH, Munne RA, Szymanski S, Safferman AZ, Pollack S, Cooper T, Kane JM, Lieberman JA. Kronig MH, et al. Among authors: kane jm. Am J Psychiatry. 1995 Feb;152(2):179-82. doi: 10.1176/ajp.152.2.179. Am J Psychiatry. 1995. PMID: 7840349

10

Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.

Lieberman JA, Safferman AZ, Pollack S, Szymanski S, Johns C, Howard A, Kronig M, Bookstein P, Kane JM. Lieberman JA, et al. Among authors: kane jm. Am J Psychiatry. 1994 Dec;151(12):1744-52. doi: 10.1176/ajp.151.12.1744. Am J Psychiatry. 1994. PMID: 7977880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

921 results

Search Page